PCR-based HIV monitor released outside US:
This article was originally published in Clinica
Executive Summary
Roche Molecular Systems has released for sale outside the US an automated version of its PCR-based test for monitoring HIV levels in infected patients. The Cobas Amplicor HIV-1 Monitor test (version 1.5), which the company claims is the first to automate the amplification and detection steps of the PCR process, will improve the accuracy and reliability of results, said the Pleasanton, California-based company. When used with the company's UltraSensitive method, the test can measure levels of HIV RNA down to as few as 50 copies/mL of plasma.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.